HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoshihide Asano Selected Research
Yoshihide Asano Research Topics
Disease
98
Systemic Scleroderma (Systemic Sclerosis)
10/2022 - 02/2003
44
Fibrosis (Cirrhosis)
10/2022 - 04/2004
27
Inflammation (Inflammations)
10/2022 - 01/2012
23
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 04/2011
22
Neoplasms (Cancer)
04/2024 - 03/2011
20
Psoriasis (Pustulosis Palmaris et Plantaris)
02/2023 - 02/2012
16
Sclerosis
07/2021 - 06/2011
15
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2024 - 12/2011
11
digital ulcers
04/2024 - 10/2011
10
Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 02/2003
8
Autoimmune Diseases (Autoimmune Disease)
10/2022 - 08/2010
8
Pulmonary Arterial Hypertension
01/2020 - 01/2010
8
Atopic Dermatitis (Atopic Eczema)
12/2018 - 10/2011
7
Mycosis Fungoides
01/2024 - 03/2013
7
Melanoma (Melanoma, Malignant)
12/2023 - 05/2022
6
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2022 - 02/2003
6
Dermatomyositis (Dermatopolymyositis)
01/2013 - 07/2002
5
Skin Diseases (Skin Disease)
01/2022 - 05/2006
5
Dermatitis
05/2021 - 07/2015
5
Localized Scleroderma (Morphea)
08/2020 - 06/2004
5
Leukemia
02/2018 - 04/2010
4
Hemangiosarcoma (Angiosarcoma)
11/2023 - 01/2023
4
Telangiectasis (Telangiectasia)
08/2021 - 01/2016
4
Ulcerative Colitis
12/2019 - 02/2011
4
Vascular System Injuries
01/2018 - 10/2011
4
Disease Progression
01/2017 - 06/2011
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2024 - 01/2011
3
Arthralgia (Joint Pain)
11/2023 - 06/2004
3
Lymphoma (Lymphomas)
11/2022 - 01/2014
3
Rheumatoid Arthritis
05/2022 - 06/2011
3
Infections
07/2021 - 07/2006
3
Pruritus (Itching)
01/2018 - 03/2013
3
Pathologic Processes
01/2017 - 05/2015
3
Wounds and Injuries (Trauma)
12/2015 - 09/2012
3
Diffuse Scleroderma (Progressive Systemic Sclerosis)
06/2014 - 10/2011
2
Skin Neoplasms (Skin Cancer)
11/2023 - 01/2023
2
Myositis (Idiopathic Inflammatory Myopathies)
04/2023 - 02/2012
2
Atherosclerosis
02/2023 - 05/2015
2
Paraproteinemias (Monoclonal Gammopathy)
06/2021 - 11/2007
Drug/Important Bio-Agent (IBA)
16
Bleomycin (Blenoxane)
FDA Link
Generic
01/2022 - 08/2010
15
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2019 - 05/2006
12
Enzymes
IBA
10/2022 - 02/2003
12
Transcription Factors (Transcription Factor)
IBA
11/2018 - 01/2010
11
Cytokines
IBA
02/2023 - 01/2010
10
Antibodies
IBA
04/2023 - 07/2002
10
Interleukin-17 (Interleukin 17)
IBA
02/2023 - 11/2011
10
Autoantibodies
IBA
10/2022 - 07/2002
9
Messenger RNA (mRNA)
IBA
03/2023 - 05/2013
9
Chemokines
IBA
01/2022 - 04/2012
8
Antigens
IBA
09/2022 - 07/2002
8
Proteins (Proteins, Gene)
FDA Link
01/2022 - 02/2012
8
indium-bleomycin
IBA
01/2018 - 04/2014
8
Immunosorbents
IBA
01/2015 - 02/2003
7
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 10/2011
7
Collagen
IBA
01/2022 - 10/2003
7
Imiquimod (Aldara)
FDA Link
Generic
05/2021 - 02/2013
7
Adiponectin
IBA
01/2019 - 09/2012
6
Rituximab (Mabthera)
FDA Link
01/2022 - 05/2014
6
Transforming Growth Factors (Transforming Growth Factor)
IBA
01/2022 - 01/2010
6
Interleukin-10 (Interleukin 10)
IBA
02/2021 - 11/2011
6
Adipokines
IBA
01/2017 - 05/2013
5
Carbon Monoxide
IBA
04/2024 - 02/2003
5
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022 - 08/2010
5
Type I DNA Topoisomerases (Topoisomerase I)
IBA
12/2021 - 11/2011
5
Interleukins
IBA
10/2021 - 08/2017
5
Ligands
IBA
05/2021 - 01/2011
5
Indicators and Reagents (Reagents)
IBA
11/2017 - 02/2003
5
Bosentan (Tracleer)
FDA Link
01/2017 - 08/2011
5
anti-scl-70 autoantibodies
IBA
01/2017 - 08/2010
4
Plasminogen Activator Inhibitor 1
IBA
01/2024 - 06/2013
4
Imatinib Mesylate (Gleevec)
FDA Link
10/2022 - 08/2008
4
Biomarkers (Surrogate Marker)
IBA
09/2022 - 02/2017
4
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2018 - 12/2015
4
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
02/2018 - 02/2005
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2018 - 02/2012
4
Nicotinamide Phosphoribosyltransferase
IBA
08/2014 - 05/2013
3
Bexarotene (LGD1069)
FDA Link
01/2024 - 11/2022
3
Immunoglobulin G (IgG)
IBA
10/2022 - 10/2005
3
Chemotactic Factors
IBA
02/2021 - 05/2014
3
anticentromere antibody
IBA
08/2020 - 04/2005
3
RNA Polymerase III
IBA
07/2020 - 05/2015
3
Adalimumab (Humira)
FDA Link
12/2019 - 10/2015
3
Steroids
IBA
11/2018 - 10/2012
3
Angiopoietin-2
IBA
02/2017 - 09/2013
3
Cell Adhesion Molecules
IBA
09/2015 - 12/2013
2
pembrolizumab
IBA
04/2024 - 01/2023
2
Nivolumab
IBA
02/2024 - 12/2017
2
Plasminogen Activators (Plasminogen Activator)
IBA
01/2024 - 11/2023
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
12/2023 - 05/2022
2
Abatacept (Orencia)
FDA Link
08/2023 - 09/2013
2
Glucocorticoids
IBA
08/2023 - 05/2020
2
taxane
IBA
07/2023 - 01/2023
2
Immune Checkpoint Inhibitors
IBA
12/2022 - 09/2022
2
Ubiquitin
IBA
10/2022 - 01/2013
2
Tacrolimus (Prograf)
FDA Link
Generic
01/2022 - 06/2011
2
Autoantigens
IBA
12/2021 - 02/2012
2
Immunoglobulin M (IgM)
IBA
06/2021 - 07/2006
Therapy/Procedure
30
Therapeutics
12/2023 - 05/2006
3
Phototherapy (Light Therapy)
06/2023 - 01/2016
2
Immunotherapy
12/2022 - 09/2022